Literature DB >> 1168869

Opsoclonus: Its clinical value.

S N Bellur.   

Abstract

Although the exact site of pathologic involvement and the pathogenesis remain uncertain, opsoclonus is an invaluable clinical sign that in it alone may herald an occult systemic malignancy. A thorough systematic evaluation should be undertaken to exclude an occult neoplasm in any patient who presents with opsoclonus unaccompanied by any other clinical sign.

Entities:  

Mesh:

Year:  1975        PMID: 1168869     DOI: 10.1212/wnl.25.6.502

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

Review 1.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Eye movement tics.

Authors:  F Shawkat; C M Harris; M Jacobs; D Taylor; E M Brett
Journal:  Br J Ophthalmol       Date:  1992-11       Impact factor: 4.638

3.  Opsoclonus as a presenting symptom in thymic carcinoma.

Authors:  M Schwartz; B Sharf; J Zidan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-06       Impact factor: 10.154

4.  Paraneoplastic opsoclonus associated with cancer of the gall bladder.

Authors:  P Corcia; B De Toffol; C Hommet; D Saudeau; A Autret
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

5.  Opsoclonus in salmonella infection.

Authors:  A Vejjajiva; P Lerdverasirikul
Journal:  Br Med J       Date:  1977-11-12

6.  Pontine lesion in opsoclonus-myoclonus syndrome shown by MRI.

Authors:  T Hattori; K Hirayama; T Imai; T Yamada; S Kojima
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

7.  Benign encephalitis: electro-oculographic analysis of opsoclonus.

Authors:  W H Zangemeister; A Müller-Jensen; S Zschocke
Journal:  J Neurol       Date:  1979       Impact factor: 4.849

8.  Cerebellar ataxia and opsoclonus as the initial manifestations of myoclonic encephalopathy associated with neuroblastoma.

Authors:  S Harel; U Yurgenson; G Rechavi; Y Burstein; Z Spirer
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.